Eli Lilly Joins the Trillion-Dollar Club, Powered by Blockbuster Weight-Loss Drugs

Life Science

Aging Population, Growing Opportunity: A Guide to Investing in Healthcare REITs

Life Science, Real Estate

Analyzing the Drivers Behind Johnson & Johnson’s Stock Price Increase This Month

Life Science

Benefiting from Both Capacity Expansion and Drug Development,  AstraZeneca’s Stock Performance Shines

Life Science

Merck’s $92 Billion Acquisition of Cidara Bets on New Flu Drug

Life Science

Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push

Life Science

Johnson & Johnson Stock Surges on Strong Earnings and Strategic Acquisition

Life Science

Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress

Life Science

Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players

Life Science

Why Is UnitedHealth Group Undervalued and Poised to Outperform Palantir?

Life Science

U.S. Stock Sell-Off Deepens: Major Indices Slide for Fourth Straight Day, Led by Tech

Consumer Goods, Life Science, Technology

With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity

Life Science

AbbVie Stock Dips Post-Earnings, But Strong Immunology Pipeline and Dividend Offer Solid Foundation

Life Science

Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs

Life Science

Why These Two Cannabis Stocks Are Gaining Attention？

Cannabis